FACULTAD DE CIENCIAS DE LA SALUD (SO)
Centro
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (15)
2023
-
Effects of a Family Caregiver Care Programme in Musculoskeletal Pain and Disability in the Shoulder-Neck Region—A Randomised Clinical Trial
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 1
-
Musculoskeletal Pain in Family Caregivers: Does a Therapeutic Physical Program in Primary Care Work? A Randomized Controlled Trial
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 1
2022
-
25-Hydroxyvitamin D Serum Levels Linked to Single Nucleotide Polymorphisms (SNPs) (rs2228570, rs2282679, rs10741657) in Skeletal Muscle Aging in Institutionalized Elderly Men Not Supplemented with Vitamin D
International Journal of Molecular Sciences, Vol. 23, Núm. 19
-
Effectiveness of Therapies Based on Mirror Neuron System to Treat Gait in Patients with Parkinson’s Disease—A Systematic Review
Journal of Clinical Medicine, Vol. 11, Núm. 14
-
Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality
Critical Care, Vol. 26, Núm. 1
-
Incidence, clinical characteristics, risk factors, and outcomes of upper gastrointestinal bleeding in patients with COVID-19 results of the UMC-19-S12
Journal of Clinical Gastroenterology, Vol. 56, Núm. 1, pp. E38-E46
2021
-
Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2
International Journal of Cardiology, Vol. 330, pp. 268-272
-
Long COVID a new derivative in the chaos of SARS-CoV-2 infection: The emergent pandemic?
Journal of Clinical Medicine, Vol. 10, Núm. 24
2020
-
Clinical perspective and translational oncology of liquid biopsy
Diagnostics, Vol. 10, Núm. 7
-
Liquid biopsy as novel tool in precision medicine: Origins, properties, identification and clinical perspective of cancer’s biomarkers
Diagnostics, Vol. 10, Núm. 4
2018
-
Clinical response to growth hormone in children with intrauterine growth retardation without catch-up growth in Castilla y León (Spain)
Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 10, pp. 584-591
2015
-
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone
Leukemia, Vol. 29, Núm. 3, pp. 705-714
2012
-
Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma
Annals of Hematology, Vol. 91, Núm. 2, pp. 257-269
2011
-
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response
Haematologica, Vol. 96, Núm. 5, pp. 687-695
2010
-
In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma
Haematologica, Vol. 95, Núm. 5, pp. 794-803